Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2020-06-01 Management Reports
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
Årsregnskap, Årsrapport og Revisjonsberetning 2019
Management Reports Classification · 99% confidence The document is very short (616 characters) and appears to be a formal statement from the Board of Directors regarding the annual accounts ('årsregnskapet') and the proposed appropriation of results (loss coverage via transfer to retained earnings, as no dividend is proposed). It is signed by the Chairman, board members, and the CEO, dated May 29, 2020. This content is highly characteristic of the formal statements typically found within a full Annual Report (10-K) or a standalone Audit Report (AR) section detailing management's assertions and proposed appropriation. Given the brevity and the focus on the final disposition of the year's result, it strongly suggests a component of the annual reporting package. Since it is not an announcement *about* a report (RPA/RNS) but rather the content itself (a formal statement/note), and it deals with the full year's results and appropriation, it aligns best with the comprehensive nature of an Annual Report (10-K) or an Audit Report (AR). As it contains the formal board statement on the financial picture and appropriation, it is a core part of the annual financial disclosure. I will classify it as an Audit Report/Information (AR) as it is a specific statement on the financial results and appropriation, which often stands alone or is a key section separate from the full 10-K filing structure, especially if this is a Norwegian filing where the 10-K equivalent might be structured differently, but the content maps directly to audit/financial review notes.
2020-06-01 Norwegian
Årsregnskap, Årsrapport og Revisjonsberetning 2019
Report Publication Announcement Classification · 95% confidence The document text explicitly mentions 'Årsregnskap, Årsrapport og Revisjonsberetning 2019' (Annual Accounts, Annual Report, and Auditor's Report 2019). This strongly indicates the presence of the full annual financial statements and the associated audit opinion. Although the text is very short, suggesting it might be an announcement, the content is the title of the comprehensive annual filing itself. Given the options, 'Annual Report (10-K)' is the closest match for a comprehensive annual filing, even if the text provided is just the title page or a brief cover notice. However, following the 'MENU VS MEAL' rule, if this is merely an announcement that the full report is available, it should be RPA or RNS. Since the text is extremely short (184 chars) and seems to be announcing the availability of the 'Signert Årsregnskap, Årsrapport og Revisjonsberetning', the most appropriate classification based on the rule is Report Publication Announcement (RPA). If the text were extensive, it would be 10-K or AR, but the brevity points to an announcement.
2020-06-01 Norwegian
Sterna Holding AS aksjesalg 21.04.20
Director's Dealing Classification · 99% confidence The document text explicitly details a sale of shares by an insider (Christian Saure, Chairman/Primary Insider via Sterna Holding AS) in Lifecare AS. It specifies the number of shares sold, the date, and the resulting ownership percentage. This directly corresponds to the definition of Director's Dealing (insider trades).
2020-04-23 Norwegian
Lifecare and Digital Diagnostics - New 5 minute coronavirus test delivers clear results on infection
Regulatory Filings Classification · 88% confidence The document describes a technological development concerning a new 5-minute coronavirus test being developed by Digital Diagnostics AG, in which Lifecare AS has a 25% ownership. The text focuses on product development, technological advantages, and future availability (prototypes in May 2020). It is not a formal regulatory filing (like 10-K, AR, IR), nor is it a standard earnings release (ER) or management discussion (MDA). It reads like a press release or a general corporate update announcing a significant business/technology development. Since there is no specific category for 'Press Release' or 'Technology Update', and the content is an announcement about a business development rather than a formal financial report or mandatory filing, the most appropriate fallback category is 'Regulatory Filings' (RNS), as it serves as a general announcement mechanism for material, non-standardized information, or 'Capital/Financing Update' (CAP) if the development implies future funding needs, but given the focus on the product announcement itself, RNS is a better fit for a general announcement of this nature, or potentially 'LTR' if it were related to legal/regulatory approval, which it is not. Given the context of a corporate announcement about a product breakthrough, RNS (Regulatory Filings/General Announcement) is the best fit among the provided options for a non-standardized corporate news item.
2020-04-21 English
Lifecare and Digital Diagnostics - New 5 minute coronavirus test delivers clear results on infection
Regulatory Filings Classification · 90% confidence The document is a short announcement detailing a joint development between Lifecare AS and Digital Diagnostics AG regarding a new 5-minute coronavirus test. It focuses on technological development, partnership terms, and the advantages of the new sensor. It is not a formal regulatory filing (like 10-K, AR, IR), nor is it a management discussion (MDA) or earnings release (ER). Since it announces a significant business/technology development and is presented as a press release (indicated by the structure and the link to a press release on the company website), it best fits the general category for miscellaneous regulatory or corporate announcements that don't fit specific financial reporting codes. Given the options, 'Regulatory Filings' (RNS) serves as the most appropriate fallback for a general corporate news announcement of this nature, as it is not a specific financial report, management change, or capital event.
2020-04-21 English
Share options for primary insiders – extended exercise period.
Director's Dealing Classification · 95% confidence The document explicitly discusses the extension of the exercise period for share options held by primary insiders (COO and CSO). This action involves transactions or changes related to executive shareholdings and compensation structures. While it touches upon insider activity, the core subject is the modification of existing option grants, which is a form of capital/financing update related to employee compensation or a specific type of insider transaction disclosure. Given the options, 'Director's Dealing' (DIRS) typically covers the actual buying/selling of shares by directors. Since this is about modifying the terms of *options* held by senior management, and it is a specific disclosure related to insider holdings/compensation terms, DIRS is the closest fit, as it covers personal share transactions by executives. However, if the focus is strictly on the *terms* of the options rather than a trade execution, it could also be seen as a specialized 'Capital/Financing Update' (CAP) or a general 'Regulatory Filing' (RNS). Given the context of 'primary insiders' and 'share options', DIRS is the most appropriate classification for executive equity changes.
2020-04-01 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.